Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Clinical trial NCT06922539 · RECRUITING

Trial details

NCT number: NCT06922539
Sponsor: SciTech Development, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Small Cell Lung Cancer

Start date: 2025-12-11
Primary completion: 2027-05-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.